Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 5, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	0	203	73	202	497	293
Market Cap Growth	-99.90%	179.01%	-64.05%	-59.37%	69.48%	56.45%
Enterprise Value	2	153	-108	101	451	206
Last Close Price	0.00	7.79	3.59	32.60	108.50	69.10
PS Ratio	0.01	20.39	4.88	8.60	32.93	147.97
PB Ratio	0.00	12.16	0.57	2.37	5.49	3.70
P/TBV Ratio	-	12.16	0.57	2.37	5.49	3.70
EV/Sales Ratio	5.07	15.38	-	4.29	29.86	104.14
Debt / Equity Ratio	-5.41	3.73	0.50	0.77	0.73	0.33
Net Debt / Equity Ratio	-0.17	-4.65	-1.09	-0.92	-1.19	-0.83
Net Debt / EBITDA Ratio	-0.02	0.62	1.12	0.81	1.36	0.87
Net Debt / FCF Ratio	-0.02	0.70	1.12	0.78	1.78	0.90
Asset Turnover	0.00	0.05	0.07	0.12	0.08	0.02
Quick Ratio	2.05	3.80	6.63	4.23	6.16	4.75
Current Ratio	2.25	3.95	6.87	4.34	6.24	4.87
Return on Equity (ROE)	-776.96%	-227.95%	-88.90%	-98.49%	-99.02%	-95.63%
Return on Assets (ROA)	-59.88%	-38.32%	-36.95%	-31.37%	-28.32%	-37.85%
Return on Capital Employed (ROCE)	-197.00%	-96.20%	-59.10%	-65.70%	-44.60%	-61.50%
Earnings Yield	-1822866.19%	-81.23%	-130.36%	-42.86%	-16.91%	-25.72%
FCF Yield	-1864591.87%	-54.29%	-171.19%	-49.91%	-12.21%	-24.86%
Buyback Yield / Dilution	-31.77%	-124.24%	-102.00%	-35.79%	-14.49%	-23.17%

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.